Surface proteomics and label-free quantification of Leptospira interrogans serovar Pomona.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
11 2021
Historique:
received: 09 09 2021
accepted: 09 11 2021
revised: 09 12 2021
pubmed: 30 11 2021
medline: 21 12 2021
entrez: 29 11 2021
Statut: epublish

Résumé

Leptospirosis is a re-emerging zoonosis with a global distribution. Surface-exposed outer membrane proteins (SE-OMPs) are crucial for bacterial-host interactions. SE-OMPs locate and expose their epitope on cell surface where is easily accessed by host molecules. This study aimed to screen for surface-exposed proteins and their abundance profile of pathogenic Leptospira interrogans serovar Pomona. Two complementary approaches, surface biotinylation and surface proteolytic shaving, followed by liquid chromatography tandem-mass spectrometry (LC-MS/MS) were employed to identify SE-OMPs of intact leptospires. For quantitative comparison, in-depth label-free analysis of SE-OMPs obtained from each method was performed using MaxQuant. The total number of proteins identified was 1,001 and 238 for surface biotinylation and proteinase K shaving, respectively. Among these, 39 were previously known SE-OMPs and 68 were predicted to be localized on the leptospiral surface. Based on MaxQuant analysis for relative quantification, six known SE-OMPs including EF- Tu, LipL21, LipL41, LipL46, Loa22, and OmpL36, and one predicted SE-OMPs, LipL71 were found in the 20 most abundant proteins, in which LipL41 was the highest abundant SE-OMP. Moreover, uncharacterized LIC14011 protein (LIP3228 ortholog in serovar Pomona) was identified as a novel predicted surface βb-OMP. High-abundance leptospiral SE-OMPs identified in this study may play roles in virulence and infection and are potential targets for development of vaccine or diagnostic tests for leptospirosis.

Identifiants

pubmed: 34843470
doi: 10.1371/journal.pntd.0009983
pii: PNTD-D-21-01340
pmc: PMC8659334
doi:

Substances chimiques

Bacterial Outer Membrane Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0009983

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Bioinformatics. 2010 Jul 1;26(13):1608-15
pubmed: 20472543
PLoS One. 2013;8(1):e51025
pubmed: 23323152
Nucleic Acids Res. 2015 Jul 1;43(W1):W408-12
pubmed: 25943549
Cold Spring Harb Protoc. 2018 Jul 2;2018(7):
pubmed: 29967277
Open Microbiol J. 2009 May 07;3:69-74
pubmed: 19590580
Biomed Res Int. 2014;2014:592858
pubmed: 24860824
Bioinformation. 2008 Jul 14;2(9):417-21
pubmed: 18795116
Curr Protoc Microbiol. 2005 Oct;Chapter 12:Unit 12E.1
pubmed: 18770554
PLoS Negl Trop Dis. 2009 Dec 08;3(12):e560
pubmed: 19997626
Trends Microbiol. 2016 Mar;24(3):198-208
pubmed: 26711681
Microbiology (Reading). 2012 Mar;158(Pt 3):622-635
pubmed: 22174381
J Proteomics. 2012 Jun 27;75(12):3733-46
pubmed: 22575384
Proteomics. 2020 Oct;20(19-20):e2000170
pubmed: 32846045
Biochim Biophys Acta. 2002 Oct 11;1565(2):308-17
pubmed: 12409203
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W400-4
pubmed: 15215419
J Proteomics. 2014 Jan 31;97:164-76
pubmed: 23624344
Protein Sci. 2004 May;13(5):1402-6
pubmed: 15096640
Proteomics. 2010 May;10(10):2037-49
pubmed: 20217865
Infect Immun. 2005 Aug;73(8):4853-63
pubmed: 16040999
Nat Methods. 2011 Sep 29;8(10):785-6
pubmed: 21959131
J Bacteriol. 2012 Nov;194(22):6074-87
pubmed: 22961849
Microbiology (Reading). 2006 Dec;152(Pt 12):3777-3786
pubmed: 17159228
Mol Biosyst. 2016 Apr 26;12(5):1420-31
pubmed: 26938107
Am J Physiol Cell Physiol. 2018 Jan 1;314(1):C99-C117
pubmed: 29046292
PLoS Negl Trop Dis. 2010 Sep 07;4(9):e815
pubmed: 20844573
FEMS Microbiol Lett. 2014 Mar;352(2):129-39
pubmed: 24289724
J Mol Biol. 2004 May 14;338(5):1027-36
pubmed: 15111065
J Vis Exp. 2011 Jul 01;(53):
pubmed: 21750491
Infect Immun. 1991 Mar;59(3):1131-40
pubmed: 1997416
Front Microbiol. 2017 Mar 14;8:396
pubmed: 28352257
Lancet Infect Dis. 2003 Dec;3(12):757-71
pubmed: 14652202
Vaccines (Basel). 2019 Aug 22;7(3):
pubmed: 31443566
Front Immunol. 2017 Apr 27;8:463
pubmed: 28496441
Biochem Biophys Res Commun. 2007 Jun 8;357(3):633-40
pubmed: 17434148
Infect Immun. 2002 May;70(5):2311-8
pubmed: 11953365
Infect Immun. 2003 May;71(5):2414-21
pubmed: 12704111
Infect Immun. 1999 Dec;67(12):6572-82
pubmed: 10569777
Vaccine. 2009 Dec 10;28(1):243-55
pubmed: 19796723
Comput Biol Chem. 2008 Jun;32(3):227-31
pubmed: 18434251
PLoS One. 2009 Jun 29;4(6):e6071
pubmed: 19562037
PLoS Pathog. 2007 Jul;3(7):e97
pubmed: 17630832
Nat Protoc. 2016 Dec;11(12):2301-2319
pubmed: 27809316
Mol Microbiol. 2003 Aug;49(4):929-45
pubmed: 12890019
BMC Genomics. 2005 Nov 17;6:162
pubmed: 16288665
Mol Microbiol. 2000 Mar;35(5):1220-34
pubmed: 10712702
PLoS One. 2013 Nov 27;8(11):e81818
pubmed: 24312361
J Biol Chem. 2002 Aug 2;277(31):27896-902
pubmed: 12023975
PLoS Negl Trop Dis. 2015 Sep 17;9(9):e0003898
pubmed: 26379143
J Mol Biol. 2001 Jan 19;305(3):567-80
pubmed: 11152613
Mol Cell Probes. 2018 Feb;37:12-21
pubmed: 29108931
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W446-51
pubmed: 19429691
Emerg Infect Dis. 2015 Dec;21(12):2141-7
pubmed: 26583534
Microbiology (Reading). 2017 Jan;163(1):37-51
pubmed: 28198346
J Theor Biol. 2010 May 21;264(2):326-33
pubmed: 20093124
Curr Opin Microbiol. 2006 Jun;9(3):320-9
pubmed: 16679049
Trans R Soc Trop Med Hyg. 2011 May;105(5):289-97
pubmed: 21353274
Nature. 2009 Aug 6;460(7256):762-5
pubmed: 19606093
Clin Vaccine Immunol. 2012 Apr;19(4):587-93
pubmed: 22323560
Vet Microbiol. 2010 Jan 27;140(3-4):287-96
pubmed: 19345023
F1000 Biol Rep. 2010 May 11;2:
pubmed: 20948798
Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W375-9
pubmed: 15215414

Auteurs

Teerasit Techawiwattanaboon (T)

Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Pathumwan, Bangkok, Thailand.
Chula Vaccine Research Center (Chula VRC), Center of Excellence in Vaccine Research and Development, Chulalongkorn University, Pathumwan, Bangkok, Thailand.

Praparat Thaibankluay (P)

Chula Vaccine Research Center (Chula VRC), Center of Excellence in Vaccine Research and Development, Chulalongkorn University, Pathumwan, Bangkok, Thailand.
Medical Science, Faculty of Medicine, Chulalongkorn University, Pathumwan, Bangkok, Thailand.

Chahya Kreangkaiwal (C)

Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Pathumwan, Bangkok, Thailand.
Chula Vaccine Research Center (Chula VRC), Center of Excellence in Vaccine Research and Development, Chulalongkorn University, Pathumwan, Bangkok, Thailand.

Suwitra Sathean-Anan-Kun (S)

Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Pathumwan, Bangkok, Thailand.
Chula Vaccine Research Center (Chula VRC), Center of Excellence in Vaccine Research and Development, Chulalongkorn University, Pathumwan, Bangkok, Thailand.

Prasong Khaenam (P)

Center for Standardization and Product Validation, Faculty of Medical Technology, Mahidol University, Bangkok-Noi, Bangkok, Thailand.

Jiradej Makjaroen (J)

Center of Excellence in Systems Biology, Research Affairs, Faculty of Medicine, Chulalongkorn University, Pathumwan, Bangkok, Thailand.

Trairak Pisitkun (T)

Center of Excellence in Systems Biology, Research Affairs, Faculty of Medicine, Chulalongkorn University, Pathumwan, Bangkok, Thailand.

Kanitha Patarakul (K)

Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Pathumwan, Bangkok, Thailand.
Chula Vaccine Research Center (Chula VRC), Center of Excellence in Vaccine Research and Development, Chulalongkorn University, Pathumwan, Bangkok, Thailand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH